Ileal perforation induced by acute radiation injury under gefitinib treatment

Takayuki Muraoka, Kazunori Tsukuda, Shinichi Toyooka, Shunsuke Kagawa, Yoshio Naomoto, Mitsuhiro Takemoto, Kuniaki Katsui, Susumu Kanazawa, Yuho Maki, Hiroko Masuda, Masaaki Harada, Hiroaki Asano, Minoru Naito, Shinichiro Miyoshi

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Enteritis is one of the side effects of radiotherapy to the abdominal cavity. Radiation enteritis involves damage to mucous membranes in the acute phase and to stromal tissues in the late phase. Perforation of the intestine tends to occur in the late phase, and rarely in the acute phase. However, we describe here a case of intestinal perforation occurring in the acute phase after irradiation in a patient who received gefitinib treatment. Gefitinib, one of the epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), is widely used to treat non-small cell lung cancer (NSCLC) patients, but is simultaneously known to inhibit wound healing. We suspect that gefitinib may affect regeneration of the small intestinal mucosa injured by irradiation. A 76-year-old woman had NSCLC with metastases to the 5th lumbar, sacral, and right iliac bones. To control the pain from bone metastasis, anterior-posterior opposing portal irradiation (total 35 Gy) was started, and was completed over 22 days. On day 25 after starting radiotherapy, the patient began to take gefitinib. On day 35, she presented with acute peritonitis, and an emergency laparotomy was performed. The terminal ileum was affected by radiation enteritis and there were two pin-hole perforations. In the surgical specimen, no cancerous lesions were detected, and immunohistochemical staining of phosphorylated EGFR (pEGFR) was negative. pEGFR has an important role in mucous membrane repair after irradiation. Intestinal perforation in the acute phase of radiation enteritis may be associated with impaired mucosal repair mechanisms due to the use of an EGFR-TKI such as gefitinib, as evidenced by the absence of pEGFR.

Original languageEnglish
Pages (from-to)774-777
Number of pages4
JournalInternational Journal of Clinical Oncology
Volume16
Issue number6
DOIs
Publication statusPublished - Dec 2011

Fingerprint

Radiation Injuries
Enteritis
Intestinal Perforation
Radiation
Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Protein-Tyrosine Kinases
Mucous Membrane
Radiotherapy
Neoplasm Metastasis
Therapeutics
Bone and Bones
Abdominal Cavity
Intestinal Mucosa
Peritonitis
Ileum
Wound Healing
Laparotomy
Intestines
Regeneration

Keywords

  • Epidermal growth factor receptor tyrosine kinase inhibitors
  • Gefitinib
  • Ileal perforation
  • Radiation enteritis

ASJC Scopus subject areas

  • Oncology
  • Surgery
  • Hematology

Cite this

Ileal perforation induced by acute radiation injury under gefitinib treatment. / Muraoka, Takayuki; Tsukuda, Kazunori; Toyooka, Shinichi; Kagawa, Shunsuke; Naomoto, Yoshio; Takemoto, Mitsuhiro; Katsui, Kuniaki; Kanazawa, Susumu; Maki, Yuho; Masuda, Hiroko; Harada, Masaaki; Asano, Hiroaki; Naito, Minoru; Miyoshi, Shinichiro.

In: International Journal of Clinical Oncology, Vol. 16, No. 6, 12.2011, p. 774-777.

Research output: Contribution to journalArticle

Muraoka, T, Tsukuda, K, Toyooka, S, Kagawa, S, Naomoto, Y, Takemoto, M, Katsui, K, Kanazawa, S, Maki, Y, Masuda, H, Harada, M, Asano, H, Naito, M & Miyoshi, S 2011, 'Ileal perforation induced by acute radiation injury under gefitinib treatment', International Journal of Clinical Oncology, vol. 16, no. 6, pp. 774-777. https://doi.org/10.1007/s10147-011-0249-8
Muraoka, Takayuki ; Tsukuda, Kazunori ; Toyooka, Shinichi ; Kagawa, Shunsuke ; Naomoto, Yoshio ; Takemoto, Mitsuhiro ; Katsui, Kuniaki ; Kanazawa, Susumu ; Maki, Yuho ; Masuda, Hiroko ; Harada, Masaaki ; Asano, Hiroaki ; Naito, Minoru ; Miyoshi, Shinichiro. / Ileal perforation induced by acute radiation injury under gefitinib treatment. In: International Journal of Clinical Oncology. 2011 ; Vol. 16, No. 6. pp. 774-777.
@article{4c452b208c1b4a4ca21aa436d24b2cba,
title = "Ileal perforation induced by acute radiation injury under gefitinib treatment",
abstract = "Enteritis is one of the side effects of radiotherapy to the abdominal cavity. Radiation enteritis involves damage to mucous membranes in the acute phase and to stromal tissues in the late phase. Perforation of the intestine tends to occur in the late phase, and rarely in the acute phase. However, we describe here a case of intestinal perforation occurring in the acute phase after irradiation in a patient who received gefitinib treatment. Gefitinib, one of the epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), is widely used to treat non-small cell lung cancer (NSCLC) patients, but is simultaneously known to inhibit wound healing. We suspect that gefitinib may affect regeneration of the small intestinal mucosa injured by irradiation. A 76-year-old woman had NSCLC with metastases to the 5th lumbar, sacral, and right iliac bones. To control the pain from bone metastasis, anterior-posterior opposing portal irradiation (total 35 Gy) was started, and was completed over 22 days. On day 25 after starting radiotherapy, the patient began to take gefitinib. On day 35, she presented with acute peritonitis, and an emergency laparotomy was performed. The terminal ileum was affected by radiation enteritis and there were two pin-hole perforations. In the surgical specimen, no cancerous lesions were detected, and immunohistochemical staining of phosphorylated EGFR (pEGFR) was negative. pEGFR has an important role in mucous membrane repair after irradiation. Intestinal perforation in the acute phase of radiation enteritis may be associated with impaired mucosal repair mechanisms due to the use of an EGFR-TKI such as gefitinib, as evidenced by the absence of pEGFR.",
keywords = "Epidermal growth factor receptor tyrosine kinase inhibitors, Gefitinib, Ileal perforation, Radiation enteritis",
author = "Takayuki Muraoka and Kazunori Tsukuda and Shinichi Toyooka and Shunsuke Kagawa and Yoshio Naomoto and Mitsuhiro Takemoto and Kuniaki Katsui and Susumu Kanazawa and Yuho Maki and Hiroko Masuda and Masaaki Harada and Hiroaki Asano and Minoru Naito and Shinichiro Miyoshi",
year = "2011",
month = "12",
doi = "10.1007/s10147-011-0249-8",
language = "English",
volume = "16",
pages = "774--777",
journal = "International Journal of Clinical Oncology",
issn = "1341-9625",
publisher = "Springer Japan",
number = "6",

}

TY - JOUR

T1 - Ileal perforation induced by acute radiation injury under gefitinib treatment

AU - Muraoka, Takayuki

AU - Tsukuda, Kazunori

AU - Toyooka, Shinichi

AU - Kagawa, Shunsuke

AU - Naomoto, Yoshio

AU - Takemoto, Mitsuhiro

AU - Katsui, Kuniaki

AU - Kanazawa, Susumu

AU - Maki, Yuho

AU - Masuda, Hiroko

AU - Harada, Masaaki

AU - Asano, Hiroaki

AU - Naito, Minoru

AU - Miyoshi, Shinichiro

PY - 2011/12

Y1 - 2011/12

N2 - Enteritis is one of the side effects of radiotherapy to the abdominal cavity. Radiation enteritis involves damage to mucous membranes in the acute phase and to stromal tissues in the late phase. Perforation of the intestine tends to occur in the late phase, and rarely in the acute phase. However, we describe here a case of intestinal perforation occurring in the acute phase after irradiation in a patient who received gefitinib treatment. Gefitinib, one of the epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), is widely used to treat non-small cell lung cancer (NSCLC) patients, but is simultaneously known to inhibit wound healing. We suspect that gefitinib may affect regeneration of the small intestinal mucosa injured by irradiation. A 76-year-old woman had NSCLC with metastases to the 5th lumbar, sacral, and right iliac bones. To control the pain from bone metastasis, anterior-posterior opposing portal irradiation (total 35 Gy) was started, and was completed over 22 days. On day 25 after starting radiotherapy, the patient began to take gefitinib. On day 35, she presented with acute peritonitis, and an emergency laparotomy was performed. The terminal ileum was affected by radiation enteritis and there were two pin-hole perforations. In the surgical specimen, no cancerous lesions were detected, and immunohistochemical staining of phosphorylated EGFR (pEGFR) was negative. pEGFR has an important role in mucous membrane repair after irradiation. Intestinal perforation in the acute phase of radiation enteritis may be associated with impaired mucosal repair mechanisms due to the use of an EGFR-TKI such as gefitinib, as evidenced by the absence of pEGFR.

AB - Enteritis is one of the side effects of radiotherapy to the abdominal cavity. Radiation enteritis involves damage to mucous membranes in the acute phase and to stromal tissues in the late phase. Perforation of the intestine tends to occur in the late phase, and rarely in the acute phase. However, we describe here a case of intestinal perforation occurring in the acute phase after irradiation in a patient who received gefitinib treatment. Gefitinib, one of the epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), is widely used to treat non-small cell lung cancer (NSCLC) patients, but is simultaneously known to inhibit wound healing. We suspect that gefitinib may affect regeneration of the small intestinal mucosa injured by irradiation. A 76-year-old woman had NSCLC with metastases to the 5th lumbar, sacral, and right iliac bones. To control the pain from bone metastasis, anterior-posterior opposing portal irradiation (total 35 Gy) was started, and was completed over 22 days. On day 25 after starting radiotherapy, the patient began to take gefitinib. On day 35, she presented with acute peritonitis, and an emergency laparotomy was performed. The terminal ileum was affected by radiation enteritis and there were two pin-hole perforations. In the surgical specimen, no cancerous lesions were detected, and immunohistochemical staining of phosphorylated EGFR (pEGFR) was negative. pEGFR has an important role in mucous membrane repair after irradiation. Intestinal perforation in the acute phase of radiation enteritis may be associated with impaired mucosal repair mechanisms due to the use of an EGFR-TKI such as gefitinib, as evidenced by the absence of pEGFR.

KW - Epidermal growth factor receptor tyrosine kinase inhibitors

KW - Gefitinib

KW - Ileal perforation

KW - Radiation enteritis

UR - http://www.scopus.com/inward/record.url?scp=84855205027&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855205027&partnerID=8YFLogxK

U2 - 10.1007/s10147-011-0249-8

DO - 10.1007/s10147-011-0249-8

M3 - Article

C2 - 21706125

AN - SCOPUS:84855205027

VL - 16

SP - 774

EP - 777

JO - International Journal of Clinical Oncology

JF - International Journal of Clinical Oncology

SN - 1341-9625

IS - 6

ER -